ABSTRACT
Trade name: Surmontil (Odyssey) Other common trade names: Apo-Trimip; Rhotrimine; Stangyl; Sumontil Indications: Major depression Category: Antineuralgic; Tricyclic antidepressant Half-life: 20-26 hours Clinically important, potentially hazardous interactions with: amprenavir,
arbutamine, bupropion, clonidine, epinephrine, formoterol, guanethidine, isocarboxazid, linezolid, MAO inhibitors, phenelzine, quinolones, sparfloxacin, tranylcypromine
Reactions
Skin Allergic reactions (sic) (<1%)
Diaphoresis (1-10%) Exanthems Petechiae Photosensitivity (<1%) Pruritus Purpura Rash (sic) Urticaria
Hair Hair-alopecia (<1%)
Other Dysgeusia (>10%)
Galactorrhea (<1%) Glossitis Gynecomastia (<1%) Paresthesias Parkinsonism (1-10%) Seizures (2001): Enns MW, J Clin Psychiatry 62(6), 476 (with bupropion) Stomatitis Tinnitus Tremor Xerostomia (>10%)
